Literature DB >> 19168511

Isoproterenol-induced heart failure in the rat is associated with nitric oxide-dependent functional alterations of cardiac function.

Peter Krenek1, Jana Kmecova, Dana Kucerova, Zuzana Bajuszova, Peter Musil, Andrea Gazova, Peter Ochodnicky, Jan Klimas, Jan Kyselovic.   

Abstract

AIMS: The role of nitric oxide (NO) in heart failure (HF) is complex and remains controversial. We tested the hypothesis that the role of NO in isolated atria and cardiomyocytes is altered in isoproterenol-induced HF. METHODS AND
RESULTS: Rats received isoproterenol (ISO, 5 mg/kg/day, intraperitoneally) or vehicle for 1 week. Haemodynamic parameters were obtained by left ventricular catheterization. Effects of NOS inhibition on isolated atria and on electrically paced left ventricular myocytes were determined. Additionally, expressions of nitric oxide synthases and their allosteric modulators hsp90, caveolin-1, and caveolin-3 proteins in the left ventricles were measured. ISO increased left ventricular mass by 33% and decreased indices of left ventricular systolic and diastolic function dp/dtmin and dp/dtmax (both P<0.05). Isolated atria from HF rats had a lower spontaneous beating rate (P<0.05). NOS inhibition by L-NAME increased basal frequency and attenuated the positive chronotropic effect of beta-adrenergic stimulation in the HF group (P<0.05). Ventricular myocytes from failing hearts had impaired cell shortening. L-NAME decreased contractility of control, but not failing myocytes. Left ventricular expressions of eNOS, hsp90, iNOS, but not nNOS or caveolins, were increased.
CONCLUSION: Despite the increased capacity for NO synthesis in isoproterenol-induced HF, NO does not sustain contractility of failing myocytes. NO may contribute to the decreased basal heart rate and it may accelerate beta-adrenergic stimulation of chronotropy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19168511      PMCID: PMC2639419          DOI: 10.1093/eurjhf/hfn026

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  35 in total

1.  The initial stage of left ventricular hypertrophy in spontaneously hypertensive rats is manifested by a decrease in the QRS amplitude/left ventricular mass ratio.

Authors:  Ljuba Bacharova; Jan Kyselovic; Jan Klimas
Journal:  Clin Exp Hypertens       Date:  2004-08       Impact factor: 1.749

Review 2.  Nitric oxide "at heart": emerging paradigms after a decade.

Authors:  M Pelat; P B Massion; J L Balligand
Journal:  Arch Mal Coeur Vaiss       Date:  2005-03

3.  beta-adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy.

Authors:  Y Shizukuda; P M Buttrick; D L Geenen; A C Borczuk; R N Kitsis; E H Sonnenblick
Journal:  Am J Physiol       Date:  1998-09

4.  Inducible nitric oxide synthase and tumor necrosis factor in animal models of myocardial necrosis induced by coronary artery ligation or isoproterenol injection.

Authors:  S A Grosjean; M A Arstall; R N Mitchell; G W Klappacher; R A Kelly; M A Pfeffer; J M Pfeffer
Journal:  J Card Fail       Date:  1999-09       Impact factor: 5.712

5.  Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction.

Authors:  Robert S Smith; Jun Agata; Chun-Fang Xia; Lee Chao; Julie Chao
Journal:  Life Sci       Date:  2005-04-08       Impact factor: 5.037

6.  Expression of inducible nitric oxide synthase in failing and non-failing human heart.

Authors:  M Thoenes; U Förstermann; W R Tracey; N M Bleese; A K Nüssler; H Scholz; B Stein
Journal:  J Mol Cell Cardiol       Date:  1996-01       Impact factor: 5.000

7.  Role of myocyte nitric oxide in beta-adrenergic hyporesponsiveness in heart failure.

Authors:  S Yamamoto; H Tsutsui; H Tagawa; K Saito; M Takahashi; H Tada; M Yamamoto; M Katoh; K Egashira; A Takeshita
Journal:  Circulation       Date:  1997-03-04       Impact factor: 29.690

8.  Cardiac oxidative stress in acute and chronic isoproterenol-infused rats.

Authors:  Guo-Xing Zhang; Shoji Kimura; Akira Nishiyama; Takatomi Shokoji; Matlubur Rahman; Li Yao; Yukiko Nagai; Yoshihide Fujisawa; Akira Miyatake; Youichi Abe
Journal:  Cardiovasc Res       Date:  2005-01-01       Impact factor: 10.787

9.  Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure.

Authors:  B Stein; T Eschenhagen; J Rüdiger; H Scholz; U Förstermann; I Gath
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

10.  Long-term beta adrenoceptor-mediated alteration in contractility and expression of phospholamban and sarcoplasmic reticulum Ca(++)-ATPase in mammalian ventricle.

Authors:  B Linck; P Bokník; H A Baba; T Eschenhagen; U Haverkamp; E Jäckel; L R Jones; U Kirchhefer; J Knapp; S Läer; F U Müller; W Schmitz; H Scholz; A Syska; U Vahlensieck; J Neumann
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

View more
  24 in total

1.  Upregulation of SERCA2a following short-term ACE inhibition (by enalaprilat) alters contractile performance and arrhythmogenicity of healthy myocardium in rat.

Authors:  Marek Matus; Dana Kucerova; Peter Kruzliak; Adriana Adameova; Gabriel Doka; Katarina Turcekova; Jana Kmecova; Jan Kyselovic; Peter Krenek; Uwe Kirchhefer; Frank U Mueller; Peter Boknik; Jan Klimas
Journal:  Mol Cell Biochem       Date:  2015-02-08       Impact factor: 3.396

2.  Exercise training inhibits inflammatory cytokines and more than prevents myocardial dysfunction in rats with sustained beta-adrenergic hyperactivity.

Authors:  Andrey J Serra; Marília H H Santos; Danilo S Bocalini; Ednei L Antônio; Rozeli F Levy; Alexandra A Santos; Maria L Higuchi; José A Silva; Flávio C Magalhães; Valério G Baraúna; José E Krieger; Paulo J F Tucci
Journal:  J Physiol       Date:  2010-05-04       Impact factor: 5.182

3.  Metformin Inhibits Isoproterenol-induced Cardiac Hypertrophy in Mice.

Authors:  Hye-Na Cha; Jung Hyun Choi; Yong-Woon Kim; Jong-Yeon Kim; Myun-Whan Ahn; So-Young Park
Journal:  Korean J Physiol Pharmacol       Date:  2010-12-31       Impact factor: 2.016

4.  Deficiency of iNOS Does Not Prevent Isoproterenol-induced Cardiac Hypertrophy in Mice.

Authors:  Hye-Na Cha; Geu-Ru Hong; Yong-Woon Kim; Jong-Yeon Kim; Jin-Myoung Dan; So-Young Park
Journal:  Korean J Physiol Pharmacol       Date:  2009-06-30       Impact factor: 2.016

5.  β1-adrenergic receptor and sphingosine-1-phosphate receptor 1 (S1PR1) reciprocal downregulation influences cardiac hypertrophic response and progression to heart failure: protective role of S1PR1 cardiac gene therapy.

Authors:  Alessandro Cannavo; Giuseppe Rengo; Daniela Liccardo; Gennaro Pagano; Carmela Zincarelli; Maria Carmen De Angelis; Roberto Puglia; Elisa Di Pietro; Joseph E Rabinowitz; Maria Vittoria Barone; Plinio Cirillo; Bruno Trimarco; Timothy M Palmer; Nicola Ferrara; Walter J Koch; Dario Leosco; Antonio Rapacciuolo
Journal:  Circulation       Date:  2013-08-22       Impact factor: 29.690

6.  Biochemical effects of Solidago virgaurea extract on experimental cardiotoxicity.

Authors:  Walid Hamdy El-Tantawy
Journal:  J Physiol Biochem       Date:  2013-07-20       Impact factor: 4.158

Review 7.  Targeting BNIP3 in inflammation-mediated heart failure: a novel concept in heart failure therapy.

Authors:  Patrick Asare Fordjour; Lingyang Wang; Hui Gao; Lan Li; Yadong Wang; Makafui Nyagblordzro; Kojo Agyemang; Guanwei Fan
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

8.  β-AR blockers suppresses ER stress in cardiac hypertrophy and heart failure.

Authors:  Li Ni; Changqing Zhou; Quanlu Duan; Jiagao Lv; Xiangning Fu; Yong Xia; Dao Wen Wang
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

9.  Meta-Analysis of Public Microarray Datasets Reveals Voltage-Gated Calcium Gene Signatures in Clinical Cancer Patients.

Authors:  Chih-Yang Wang; Ming-Derg Lai; Nam Nhut Phan; Zhengda Sun; Yen-Chang Lin
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

10.  Mouse strain determines cardiac growth potential.

Authors:  Carmen Kiper; Barry Grimes; Gary Van Zant; Jonathan Satin
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.